Daxor (DXR) vs Spectral AI (MDAI)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Daxor (DXR) has outperformed Spectral AI (MDAI) over the past year, losing 20.0% versus a loss of 35.2%. Over five years, DXR leads with a -7.0% price change compared with -83.2% for MDAI. Daxor is the larger company by market cap ($61.8 million vs $53.7 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | DXR | MDAI |
|---|---|---|
| Share price | $10.58 | $1.67 |
| Market cap | $61.77M | $53.75M |
| 1-day change | +1.15% | +1.83% |
| YTD return | -29.08% | +15.49% |
| 1-year return | -20.03% | -35.18% |
| 5-year return | -7.02% | -83.20% |
| P/E ratio (TTM) | 9.62 | — |
| EPS (TTM) | $1.10 | $-0.32 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $14.76 | $2.97 |
| 52-week low | $8.56 | $1.18 |
| Distance from 52-week high | -28.32% | -43.77% |
| Analyst consensus | none | none |
| Avg. price target upside | +89.04% | +205.99% |
| Average volume | 17.27K | 150.48K |
| Shares outstanding | 5.84M | 32.18M |
| Employees | — | 65 |
| Sector | Health Care | Health Care |
| Industry | Medical/Dental Instruments | Medical/Dental Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- DXR has outperformed MDAI by 15.1 percentage points over the past year.
About Daxor
DXR stock →Daxor Corporation engages in medical instrumentation and biotechnology operations. It develops the BVA-100 Blood Volume Analyzer, an instrument that measures human blood volume, in conjunction with Volumex, a single-use radiopharmaceutical diagnostic injection and collection kit.
Health Care · Medical/Dental Instruments
About Spectral AI
MDAI stock →Spectral AI, Inc., an artificial intelligence (AI) company, focuses on predictive medical diagnostics in the United States. The company offers DeepView System, which uses proprietary AI algorithms to distinguish between fully damaged, partially damaged, and healthy human tissue characteristics invisible to the naked eye at the initial time point of wound presentation and delivers a binary prediction on the wounds capacity to heal by a specified time point in the future to assist the physician in making a more accurate, timely, and informed decision regarding the treatment of the patient's wounds.
Health Care · Medical/Dental Instruments · 65 employees
DXR vs MDAI FAQ
Which is bigger, Daxor or Spectral AI?
Daxor (DXR) is larger, with a market capitalization of $61.77M compared with $53.75M for Spectral AI (MDAI).
Which stock has performed better over the past year, DXR or MDAI?
DXR returned -20.03% over the past 12 months, compared with -35.18% for MDAI (price return, excluding dividends). Past performance does not predict future results.
Are Daxor and Spectral AI in the same industry?
Yes. Both are classified in the Medical/Dental Instruments industry within the Health Care sector.